Dysfunctional Hemoglobin
NCT02262195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62
Last updated 2015-04-21
Summary
The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.
Conditions
- Elevated Levels of Carboxyhemoglobin and Methemoglobin
Interventions
- OTHER
-
Elevated levels of carboxyhemoglobin
Comparison of pulse co-oximeters
Sponsors & Collaborators
-
University of California, San Francisco
collaborator OTHER -
Nonin Medical, Inc
lead INDUSTRY
Principal Investigators
-
Phillip E Bickler, MD, PhD · University of San Francisco
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular Biology of Polycythemia and Thrombocytosis
NCT00722527 ·Status: RECRUITING
-
Evaluation of Sickle Cell Liver Disease
NCT01950429 ·Status: COMPLETED
-
The Impact of Oxidative Stress on Erythrocyte Biology
NCT04028700 ·Status: TERMINATED ·Phase: PHASE2
-
Non-Invasive Estimation of Hemoglobin Levels in Blood Using Combined Deep Learning Methods
NCT04865224 ·Status: COMPLETED
-
Safety Study of MP4CO in Adult Sickle Cell Patients
NCT01356485 ·Status: COMPLETED ·Phase: PHASE1
-
Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease
NCT00012545 ·Status: COMPLETED
-
The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease
NCT00451919 ·Status: COMPLETED
-
Hyperbaric Oxygen Therapy in Sickle Cell Pain
NCT03412045 ·Status: COMPLETED ·Phase: NA
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 ·Status: COMPLETED
-
Long-term Endurance Training in Sickle Cell Disease Patients: Impact on Clinical Profile, Physical Fitness, and Quality of Life.
NCT06823219 ·Status: RECRUITING ·Phase: NA
-
Fetal Hemoglobin Induction Treatment Metformin
NCT02981329 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease
NCT03629678 ·Status: COMPLETED ·Phase: NA
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD)
NCT05604547 ·Status: COMPLETED
-
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
NCT00993694 ·Status: COMPLETED
-
Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)
NCT05289700 ·Status: UNKNOWN ·Phase: PHASE3
-
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels
NCT04263571 ·Status: UNKNOWN
-
Oxidative Stress and Iron Overload in Patient With Abnormal Haemoglobinopathy
NCT05586932 ·Status: UNKNOWN
-
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
NCT04594031 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease
NCT03977532 ·Status: COMPLETED ·Phase: NA
-
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 ·Status: COMPLETED
-
Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation
NCT06619093 ·Status: NOT_YET_RECRUITING